Literature DB >> 11914171

Diagnosis and treatment of body dysmorphic disorder in adolescents.

Sallie Jo Hadley1, Jennifer Greenberg, Eric Hollander.   

Abstract

Body dysmorphic disorder (BDD) is an underrecognized and underdiagnosed problem that is relatively common among adolescents. Although the onset of the disorder occurs in adolescence, BDD research in child and adolescent psychiatry is relatively limited. Body dysmorphic disorder has a high rate of co-morbidity with depression and suicide, which indicates important implications for prompt diagnosis and treatment in adolescents with BDD. Effective treatment options include cognitive behavioral therapy (CBT) and pharmacotherapy with serotonin reuptake inhibitors (SRIs). This paper provides a brief overview of BDD in adolescents, presents and evaluates the most recent literature on approaches to diagnosis and treatment, and highlights some of the characteristics that distinguish BDD from other disorders such as obsessive-compulsive disorder, social phobia, depression, and eating disorders.

Entities:  

Mesh:

Year:  2002        PMID: 11914171     DOI: 10.1007/s11920-002-0043-4

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  26 in total

1.  Rate of body dysmorphic disorder in dermatology patients.

Authors:  K A Phillips; R G Dufresne; C S Wilkel; C C Vittorio
Journal:  J Am Acad Dermatol       Date:  2000-03       Impact factor: 11.527

Review 2.  Treatment of body-dysmorphic disorder with serotonin reuptake blockers.

Authors:  E Hollander; M R Liebowitz; R Winchel; A Klumker; D F Klein
Journal:  Am J Psychiatry       Date:  1989-06       Impact factor: 18.112

3.  Efficacy and safety of fluvoxamine in body dysmorphic disorder.

Authors:  K A Phillips; M M Dwight; S L McElroy
Journal:  J Clin Psychiatry       Date:  1998-04       Impact factor: 4.384

4.  Two-year follow-up of behavioral treatment and maintenance for body dysmorphic disorder.

Authors:  D McKay
Journal:  Behav Modif       Date:  1999-10

5.  Sertraline for body dysmorphic disorder.

Authors:  H E el-Khatib; T O Dickey
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1995-11       Impact factor: 8.829

6.  Fluvoxamine treatment of body dysmorphic disorder.

Authors:  E Hollander; L Cohen; D Simeon; J Rosen; C DeCaria; D J Stein
Journal:  J Clin Psychopharmacol       Date:  1994-02       Impact factor: 3.153

7.  Thirty-three cases of body dysmorphic disorder in children and adolescents.

Authors:  R S Albertini; K A Phillips
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1999-04       Impact factor: 8.829

8.  Prevalence and clinical features of body dysmorphic disorder in adolescent and adult psychiatric inpatients.

Authors:  J E Grant; S W Kim; S J Crow
Journal:  J Clin Psychiatry       Date:  2001-07       Impact factor: 4.384

Review 9.  Pharmacologic treatment of body dysmorphic disorder.

Authors:  K A Phillips
Journal:  Psychopharmacol Bull       Date:  1996

Review 10.  Body dysmorphic disorder: diagnostic controversies and treatment challenges.

Authors:  K A Phillips
Journal:  Bull Menninger Clin       Date:  2000
View more
  3 in total

1.  Cosmetic and reconstructive breast surgery in adolescents: psychological, ethical, and legal considerations.

Authors:  Canice E Crerand; Leanne Magee
Journal:  Semin Plast Surg       Date:  2013-02       Impact factor: 2.314

Review 2.  Cognitive-behavioral therapy for youth with body dysmorphic disorder: current status and future directions.

Authors:  Katharine A Phillips; Jamison Rogers
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2011-04

3.  Considerations in breast augmentation in the adolescent patient.

Authors:  Sumanas W Jordan; Julia Corcoran
Journal:  Semin Plast Surg       Date:  2013-02       Impact factor: 2.314

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.